Charles L. Spurr

4.4k total citations
107 papers, 2.6k citations indexed

About

Charles L. Spurr is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Charles L. Spurr has authored 107 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 22 papers in Pathology and Forensic Medicine. Recurrent topics in Charles L. Spurr's work include Cancer Treatment and Pharmacology (21 papers), Lymphoma Diagnosis and Treatment (17 papers) and Lung Cancer Treatments and Mutations (13 papers). Charles L. Spurr is often cited by papers focused on Cancer Treatment and Pharmacology (21 papers), Lymphoma Diagnosis and Treatment (17 papers) and Lung Cancer Treatments and Mutations (13 papers). Charles L. Spurr collaborates with scholars based in United States, United Kingdom and South Africa. Charles L. Spurr's co-authors include M. Robert Cooper, Frederick Richards, Don V. Jackson, Dougľas R. White, Hyman B. Muss, John J. Stuart, Lawrence R. DeChatelet, Robert L. Capizzi, Charles E. McCall and Ralph V. Ford and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Charles L. Spurr

104 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles L. Spurr United States 28 1.0k 470 446 394 341 107 2.6k
Frederick Richards United States 29 1.2k 1.2× 497 1.1× 272 0.6× 457 1.2× 302 0.9× 100 2.5k
Richard A. Gams United States 20 968 0.9× 393 0.8× 441 1.0× 373 0.9× 171 0.5× 64 2.1k
Tom Anderson United States 32 1.6k 1.6× 820 1.7× 798 1.8× 730 1.9× 217 0.6× 88 3.7k
B. J. Kennedy United States 28 732 0.7× 962 2.0× 308 0.7× 530 1.3× 114 0.3× 82 2.7k
P M Wilkinson United Kingdom 31 1.0k 1.0× 799 1.7× 607 1.4× 553 1.4× 230 0.7× 87 3.4k
William P. Peters United States 28 875 0.8× 400 0.9× 206 0.5× 561 1.4× 132 0.4× 68 2.5k
G. Bonadonna Italy 25 1.9k 1.9× 585 1.2× 788 1.8× 468 1.2× 156 0.5× 72 3.3k
N. Tubiana-Mathieu France 30 2.0k 1.9× 644 1.4× 495 1.1× 436 1.1× 186 0.5× 166 3.2k
David L. Ahmann United States 29 1.8k 1.7× 460 1.0× 421 0.9× 637 1.6× 170 0.5× 70 3.1k
F. Cavalli Switzerland 33 2.2k 2.1× 660 1.4× 1.5k 3.3× 705 1.8× 322 0.9× 147 4.0k

Countries citing papers authored by Charles L. Spurr

Since Specialization
Citations

This map shows the geographic impact of Charles L. Spurr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles L. Spurr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles L. Spurr more than expected).

Fields of papers citing papers by Charles L. Spurr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles L. Spurr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles L. Spurr. The network helps show where Charles L. Spurr may publish in the future.

Co-authorship network of co-authors of Charles L. Spurr

This figure shows the co-authorship network connecting the top 25 collaborators of Charles L. Spurr. A scholar is included among the top collaborators of Charles L. Spurr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles L. Spurr. Charles L. Spurr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherid, Muhammed, Samian Sulaiman, Salih Samo, et al.. (2016). Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin. Gastroenterology Research and Practice. 2016. 1–9. 6 indexed citations
2.
Sherid, Muhammed, Salih Samo, Samian Sulaiman, et al.. (2016). Comparison of Ischemic Colitis in the Young and the Elderly.. PubMed. 115(4). 196–202. 4 indexed citations
3.
Sherid, Muhammed, Humberto Sifuentes, Salih Samo, et al.. (2014). Risk Factors of Recurrent Ischemic Colitis: A Multicenter Retrospective Study. Korean Journal of Gastroenterology. 63(5). 283–283. 9 indexed citations
4.
Muss, Hyman B., L. Douglas Case, Robert L. Capizzi, et al.. (1990). High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.. Journal of Clinical Oncology. 8(11). 1797–1805. 61 indexed citations
5.
Richards, Fred, L. Douglas Case, Dougľas R. White, et al.. (1986). Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.. Journal of Clinical Oncology. 4(4). 565–570. 23 indexed citations
6.
Jackson, Don V., et al.. (1985). Phase II study of vincristine infusion in refractory small cell carcinoma of the lung. American Journal of Clinical Oncology. 8(2). 154–156. 2 indexed citations
7.
Powell, Bayard L., Don V. Jackson, Charles W. Scarantino, et al.. (1985). Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: A preliminary analysis. International Journal of Radiation Oncology*Biology*Physics. 11(3). 457–462. 10 indexed citations
8.
Jackson, Don V., Eugene Paschold, Charles L. Spurr, et al.. (1984). Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion. Cancer. 53(12). 2601–2606. 36 indexed citations
9.
Jackson, Don V., et al.. (1984). Hepatic intra-arterial infusion of vincristine. Cancer Chemotherapy and Pharmacology. 13(2). 120–122. 1 indexed citations
10.
Jackson, Don V., Wayne Meredith, V.Sagar Sethi, et al.. (1983). Continuous intravenous infusion of vinca alkaloid using a subcutaneously implanted pump in a canine model. Cancer Chemotherapy and Pharmacology. 10(3). 217–220. 5 indexed citations
11.
Jackson, Don V., H. Bradley Wells, Dougľas R. White, et al.. (1983). Lack of potentiation of vincristine-induced neurotoxicity by VP-16–213. American Journal of Clinical Oncology. 6(3). 327–330. 13 indexed citations
12.
Jackson, Don V., Dougľas R. White, Hyman B. Muss, et al.. (1983). Vincristine by continuous infusion in refractory breast cancer. American Journal of Clinical Oncology. 6(5). 529–532. 3 indexed citations
13.
Muss, Hyman B., Frederick Richards, M. Robert Cooper, et al.. (1982). Nonseminomatous germ cell cancer of the testis. Reducing treatment-related morbidity in patients with disseminated disease. Cancer. 50(9). 1742–1745. 4 indexed citations
14.
15.
Hayes, Donald M., Thomas F. Pajak, Vishram B. Rege, et al.. (1979). Combination chemotherapy for non‐Hodgkin lymphomas: A ten year follow‐up study. Medical and Pediatric Oncology. 6(1). 23–38. 2 indexed citations
16.
Richards, Frederick, et al.. (1978). The control of chronic lymphocytic leukemia with mediastinal irradiation. The American Journal of Medicine. 64(6). 947–954. 11 indexed citations
17.
Pp, Carbone, Charles L. Spurr, Marvin A. Schneiderman, et al.. (1968). Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids.. PubMed. 28(5). 811–22. 108 indexed citations
18.
Jh, Moyer, et al.. (1958). Results of laboratory and clinical studies on three new mercurial diuretics and a comparison with those currently available.. PubMed. 5(4). 254–65. 1 indexed citations
19.
Ford, Ralph V., Charles L. Spurr, & John H. Moyer. (1957). The problem of bioassay and comparative potency of diuretics. I. Parenteral and oral mercurial diuretics.. PubMed. 4(11). 708–24. 5 indexed citations
20.
Spurr, Charles L., et al.. (1956). Myleran in the Treatment of Chronic Myeloid Leukemia. Southern Medical Journal. 49(8). 847–855. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frederick Richards Breakdown of academic impact, for papers by Richard A. Gams Breakdown of academic impact, for papers by Tom Anderson Breakdown of academic impact, for papers by B. J. Kennedy Breakdown of academic impact, for papers by P M Wilkinson Breakdown of academic impact, for papers by William P. Peters Breakdown of academic impact, for papers by G. Bonadonna Breakdown of academic impact, for papers by N. Tubiana-Mathieu Breakdown of academic impact, for papers by David L. Ahmann Breakdown of academic impact, for papers by F. Cavalli
Rankless by CCL
2026